At the time of writing, Mangoceuticals Inc [MGRX] stock is trading at $0.28, up 20.45%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The MGRX shares have gain 32.33% over the last week, with a monthly amount glided 33.26%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 12, March 2024, MangoRx Officially Launches ‘PRIME’ by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Treatment. In a post published today on Yahoo Finance, The Dallas Based, Direct-to-Consumer Telemedicine Company Brings the FDA-Approved Oral Testosterone Replacement Therapy Treatment to the Telehealth Market.
From an analyst’s perspective:
For the past year, the stock price of Mangoceuticals Inc fluctuated between $0.14 and $3.18. Mangoceuticals Inc [NASDAQ: MGRX] shares were valued at $0.28 at the most recent close of the market.
Analyzing the MGRX fundamentals
According to Mangoceuticals Inc [NASDAQ:MGRX], the company’s sales were 0.73M for trailing twelve months, which represents an 2633.80% jump. Gross Profit Margin for this corporation currently stands at 0.59% with Operating Profit Margin at -12.6%, Pretax Profit Margin comes in at -12.59%, and Net Profit Margin reading is -12.59%. To continue investigating profitability, this company’s Return on Assets is posted at -8.77, Equity is -4.12 and Total Capital is -10.98. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.08.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.2420 points at the first support level, and at 0.1995 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.3060, and for the 2nd resistance point, it is at 0.3275.
Ratios To Look Out For
It is important to note that Mangoceuticals Inc [NASDAQ:MGRX] has a current ratio of 3.88. Also, the Quick Ratio is 3.79, while the Cash Ratio stands at 3.5. Considering the valuation of this stock, the price to sales ratio is 8.95, the price to book ratio is 7.87.
Transactions by insiders
Recent insider trading involved Cohen Jacob D., Chief Executive Officer, that happened on Apr 10 ’23 when 0.28 million shares were purchased.
